Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Donaldson

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Cancer|December 15, 1982
Tumor regression and histologic clearance after neutron brachytherapy for bulky localized cervical carcinomaY Maruyama, J Yoneda, J R Van Nagell, et al.
Gynecologic Oncology|June 1, 1977
The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgeryJ R Van Nagel, E S Donaldson, J C Parker, et al.
Cancer|June 1, 1977
The prognostic significance of pelvic lymph node morphology in carcinoma of the uterine cervixJ R van Nagell, E S Donaldson, J C Parker, et al.
Cancer|November 1, 1978
Carcinoembryonic antigen in carcinoma of the uterine cervix. 1. The prognostic value of serial plasma determinationsJ R van Nagell, E S Donaldson, E C Gay, et al.
American Journal of Obstetrics and Gynecology|April 15, 1983
Microinvasive carcinoma of the cervixJ R van Nagell, N Greenwell, D F Powell, et al.
Biochemistry|June 5, 1984
Estrogenicity of coumestrol in the mouse: fluorescence detection of interaction with estrogen receptorsK Nelson, E J Pavlik, J R van Nagell, et al.
Cancer|June 1, 1978
Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinationsJ R van Nagell, E S Donaldson, E C Gay, et al.
Gynecologic Oncology|January 1, 1990
The efficacy of laser therapy in the treatment of cervical intraepithelial neoplasiaR V Higgins, J R van Nagell, E S Donaldson, et al.
Gynecologic Oncology|October 1, 1982
Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell lineE J Pavlik, J R van Nagell, M B Hanson, et al.
Cancer|March 15, 1989
Adjuvant oral alkylating chemotherapy in patients with stage I epithelial ovarian cancerH H Gallion, J R van Nagell, E S Donaldson, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Cancer|December 15, 1982
Tumor regression and histologic clearance after neutron brachytherapy for bulky localized cervical carcinomaY Maruyama, J Yoneda, J R Van Nagell, et al.
Gynecologic Oncology|June 1, 1977
The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgeryJ R Van Nagel, E S Donaldson, J C Parker, et al.
Cancer|June 1, 1977
The prognostic significance of pelvic lymph node morphology in carcinoma of the uterine cervixJ R van Nagell, E S Donaldson, J C Parker, et al.
Cancer|November 1, 1978
Carcinoembryonic antigen in carcinoma of the uterine cervix. 1. The prognostic value of serial plasma determinationsJ R van Nagell, E S Donaldson, E C Gay, et al.
American Journal of Obstetrics and Gynecology|April 15, 1983
Microinvasive carcinoma of the cervixJ R van Nagell, N Greenwell, D F Powell, et al.
Biochemistry|June 5, 1984
Estrogenicity of coumestrol in the mouse: fluorescence detection of interaction with estrogen receptorsK Nelson, E J Pavlik, J R van Nagell, et al.
Cancer|June 1, 1978
Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinationsJ R van Nagell, E S Donaldson, E C Gay, et al.
Gynecologic Oncology|January 1, 1990
The efficacy of laser therapy in the treatment of cervical intraepithelial neoplasiaR V Higgins, J R van Nagell, E S Donaldson, et al.
Gynecologic Oncology|October 1, 1982
Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell lineE J Pavlik, J R van Nagell, M B Hanson, et al.
Cancer|March 15, 1989
Adjuvant oral alkylating chemotherapy in patients with stage I epithelial ovarian cancerH H Gallion, J R van Nagell, E S Donaldson, et al.
Pageof 8